Valuation Update With 7 Day Price Move • Jun 25
Investor sentiment improves as stock rises 19% After last week's 19% share price gain to CN¥25.68, the stock trades at a forward P/E ratio of 9x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 89% over the past three years. Declared Dividend • Jun 06
Dividend of CN¥0.50 announced Shareholders will receive a dividend of CN¥0.50. Ex-date: 12th June 2026 Payment date: 12th June 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.6%. Sustainability & Growth Dividend is well covered by both earnings (29% earnings payout ratio) and cash flows (22% cash payout ratio). The dividend has increased by an average of 32% per year over the past 9 years. However, payments have been volatile during that time. EPS is expected to grow by 59% over the next 3 years, which should provide support to the dividend and adequate earnings cover. Board Change • May 20
High number of new directors There are 5 new directors who have joined the board in the last 3 years. VP & Non-Independent Director Jun Gao was the last director to join the board, commencing their role in 2024. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. Duyuru • Mar 31
Satellite Chemical Co.,Ltd. to Report Q1, 2026 Results on Apr 14, 2026 Satellite Chemical Co.,Ltd. announced that they will report Q1, 2026 results on Apr 14, 2026 Duyuru • Mar 23
Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026 Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 13, 2026, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang China Duyuru • Dec 31
Satellite Chemical Co.,Ltd. to Report Fiscal Year 2025 Results on Mar 24, 2026 Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2025 results on Mar 24, 2026 Duyuru • Sep 30
Satellite Chemical Co.,Ltd. to Report Q3, 2025 Results on Oct 25, 2025 Satellite Chemical Co.,Ltd. announced that they will report Q3, 2025 results on Oct 25, 2025 Duyuru • Jul 02
Satellite Chemical Co.,Ltd. to Report First Half, 2025 Results on Aug 12, 2025 Satellite Chemical Co.,Ltd. announced that they will report first half, 2025 results on Aug 12, 2025 Duyuru • Apr 16
Satellite Chemical Co.,Ltd. Approves Cash Dividend for the Year 2024 Satellite Chemical Co.,Ltd. held its Annual General Meeting of 2024 on April 14, 2025, approved cash dividend of CNY5.00000000 per ten shares (tax included) for 2024. Duyuru • Apr 11
Satellite Chemical Co.,Ltd. (SZSE:002648) announces an Equity Buyback for CNY 400 million worth of its shares. Satellite Chemical Co.,Ltd. (SZSE:002648) announces a share repurchase program. Under the program, the company will repurchase up to CNY 400 million worth of its A shares. The repurchase price will not exceed CNY 29.50 per share. The purpose of the buyback is to implement the company’s business partner shareholding plan or other equity incentives plans. The repurchase will be funded through own funds or self-financing. The repurchase period will be not more than 12 months from the approval date. Duyuru • Mar 31
Satellite Chemical Co.,Ltd. to Report Q1, 2025 Results on Apr 15, 2025 Satellite Chemical Co.,Ltd. announced that they will report Q1, 2025 results on Apr 15, 2025 Duyuru • Mar 26
Satellite Chemical Co.,Ltd. Proposes Final Dividend for 2024 Satellite Chemical Co.,Ltd. announced on 25 March 2025 the profit distribution proposal for 2024 as follows: Cash dividend per 10 shares (tax included) of CNY 5.00000000. Duyuru • Mar 25
Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025 Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 14, 2025, at 14:00 China Standard Time. Location: No. 196, Fuqiang Road, Nanhu District, Jiaxing, Zhejiang China Duyuru • Dec 31
Satellite Chemical Co.,Ltd. to Report Fiscal Year 2024 Results on Mar 25, 2025 Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2024 results on Mar 25, 2025 Reported Earnings • Oct 22
Third quarter 2024 earnings released: EPS: CN¥0.49 (vs CN¥0.46 in 3Q 2023) Third quarter 2024 results: EPS: CN¥0.49 (up from CN¥0.46 in 3Q 2023). Revenue: CN¥12.9b (up 19% from 3Q 2023). Net income: CN¥1.64b (up 5.4% from 3Q 2023). Profit margin: 13% (down from 14% in 3Q 2023). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 19% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 5% per year. Duyuru • Sep 30
Satellite Chemical Co.,Ltd. to Report Q3, 2024 Results on Oct 22, 2024 Satellite Chemical Co.,Ltd. announced that they will report Q3, 2024 results on Oct 22, 2024 Valuation Update With 7 Day Price Move • Sep 27
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to CN¥17.51, the stock trades at a forward P/E ratio of 10x. Average forward P/E is 16x in the Chemicals industry in China. Total loss to shareholders of 7.6% over the past three years. Reported Earnings • Jul 20
Second quarter 2024 earnings released: EPS: CN¥0.31 (vs CN¥0.33 in 2Q 2023) Second quarter 2024 results: EPS: CN¥0.31 (down from CN¥0.33 in 2Q 2023). Revenue: CN¥10.6b (down 2.5% from 2Q 2023). Net income: CN¥1.03b (down 8.5% from 2Q 2023). Profit margin: 9.8% (in line with 2Q 2023). Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 15% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 8% per year whereas the company’s share price has fallen by 3% per year. Duyuru • Jun 29
Satellite Chemical Co.,Ltd. to Report First Half, 2024 Results on Jul 18, 2024 Satellite Chemical Co.,Ltd. announced that they will report first half, 2024 results on Jul 18, 2024 Reported Earnings • Apr 23
First quarter 2024 earnings released: EPS: CN¥0.30 (vs CN¥0.21 in 1Q 2023) First quarter 2024 results: EPS: CN¥0.30 (up from CN¥0.21 in 1Q 2023). Revenue: CN¥8.80b (down 6.5% from 1Q 2023). Net income: CN¥1.02b (up 45% from 1Q 2023). Profit margin: 12% (up from 7.5% in 1Q 2023). The increase in margin was driven by lower expenses. Revenue is forecast to grow 16% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has fallen by 5% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings. Duyuru • Mar 30
Satellite Chemical Co.,Ltd. to Report Q1, 2024 Results on Apr 23, 2024 Satellite Chemical Co.,Ltd. announced that they will report Q1, 2024 results on Apr 23, 2024 Duyuru • Mar 26
Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024 Satellite Chemical Co.,Ltd., Annual General Meeting, Apr 15, 2024, at 13:30 China Standard Time. Location: The Company's Meeting Room, Jiaxing, Zhejiang China Reported Earnings • Mar 12
Full year 2023 earnings released: EPS: CN¥1.43 (vs CN¥0.91 in FY 2022) Full year 2023 results: EPS: CN¥1.43 (up from CN¥0.91 in FY 2022). Revenue: CN¥40.7b (up 10.0% from FY 2022). Net income: CN¥4.80b (up 57% from FY 2022). Profit margin: 12% (up from 8.3% in FY 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 16% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has remained flat but the company’s share price has increased by 6% per year, which means it is well ahead of earnings. Duyuru • Dec 30
Satellite Chemical Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 26, 2024 Satellite Chemical Co.,Ltd. announced that they will report fiscal year 2023 results on Mar 26, 2024 Reported Earnings • Oct 25
Third quarter 2023 earnings released: EPS: CN¥0.46 (vs CN¥0.071 in 3Q 2022) Third quarter 2023 results: EPS: CN¥0.46 (up from CN¥0.071 in 3Q 2022). Revenue: CN¥10.9b (up 21% from 3Q 2022). Net income: CN¥1.55b (up CN¥1.32b from 3Q 2022). Profit margin: 14% (up from 2.6% in 3Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 14% p.a. on average during the next 3 years, compared to a 19% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 6% per year but the company’s share price has increased by 27% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Sep 30
Satellite Chemical Co.,Ltd. to Report Q3, 2023 Results on Oct 25, 2023 Satellite Chemical Co.,Ltd. announced that they will report Q3, 2023 results on Oct 25, 2023 Reported Earnings • Jul 18
Second quarter 2023 earnings released: EPS: CN¥0.34 (vs CN¥0.37 in 2Q 2022) Second quarter 2023 results: EPS: CN¥0.34 (down from CN¥0.37 in 2Q 2022). Revenue: CN¥10.6b (flat on 2Q 2022). Net income: CN¥1.13b (down 10% from 2Q 2022). Profit margin: 11% (down from 12% in 2Q 2022). Revenue is forecast to grow 13% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 17% per year but the company’s share price has increased by 32% per year, which means it is tracking significantly ahead of earnings growth. Duyuru • Jul 01
Satellite Chemical Co.,Ltd. to Report First Half, 2023 Results on Jul 18, 2023 Satellite Chemical Co.,Ltd. announced that they will report first half, 2023 results on Jul 18, 2023 Duyuru • May 06
Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023 Satellite Chemical Co.,Ltd., Annual General Meeting, May 19, 2023, at 09:30 China Standard Time. Agenda: To consider 2022 work report of the board of directors; to consider 2022 work report of the supervisory committee; to consider 2022 annual accounts; to consider Launching foreign exchange hedging business; and to discuss other matters. Reported Earnings • Apr 29
First quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.45 in 1Q 2022) First quarter 2023 results: EPS: CN¥0.21 (down from CN¥0.45 in 1Q 2022). Revenue: CN¥9.42b (up 16% from 1Q 2022). Net income: CN¥707.2m (down 54% from 1Q 2022). Profit margin: 7.5% (down from 19% in 1Q 2022). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 14% p.a. on average during the next 2 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 32% per year but the company’s share price has increased by 41% per year, which means it is tracking significantly ahead of earnings growth. Board Change • Nov 16
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Oct 25
Third quarter 2022 earnings released: EPS: CN¥0.53 (vs CN¥0.63 in 3Q 2021) Third quarter 2022 results: EPS: CN¥0.53 (down from CN¥0.63 in 3Q 2021). Revenue: CN¥8.96b (down 3.2% from 3Q 2021). Net income: CN¥235.0m (down 89% from 3Q 2021). Profit margin: 2.6% (down from 23% in 3Q 2021). The decrease in margin was primarily driven by higher expenses. Revenue is forecast to grow 18% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 38% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Oct 06
Upcoming dividend of CN¥0.40 per share Eligible shareholders must have bought the stock before 13 October 2022. Payment date: 13 October 2022. Payout ratio is a comfortable 9.0% and this is well supported by cash flows. Trailing yield: 1.2%. Lower than top quartile of Chinese dividend payers (2.2%). Lower than average of industry peers (1.8%). Reported Earnings • Sep 02
Second quarter 2022 earnings released: EPS: CN¥0.52 (vs CN¥0.57 in 2Q 2021) Second quarter 2022 results: EPS: CN¥0.52 (down from CN¥0.57 in 2Q 2021). Revenue: CN¥10.7b (up 49% from 2Q 2021). Net income: CN¥1.26b (down 7.3% from 2Q 2021). Profit margin: 12% (down from 19% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 26%, compared to a 33% growth forecast for the Chemicals industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 45% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 15
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥25.71, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 18x in the Chemicals industry in China. Total returns to shareholders of 304% over the past three years. Board Change • May 13
Less than half of directors are independent There is 1 new director who has joined the board in the last 3 years. The new board member was not an independent director. The company's board is composed of: 1 new director. 9 experienced directors. No highly experienced directors. 3 independent directors (4 non-independent directors). Supervisor Xiaolong Hu was the last director to join the board, commencing their role in 2020. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Reported Earnings • Apr 28
First quarter 2022 earnings released: EPS: CN¥0.89 (vs CN¥0.44 in 1Q 2021) First quarter 2022 results: EPS: CN¥0.89 (up from CN¥0.44 in 1Q 2021). Revenue: CN¥8.14b (up 125% from 1Q 2021). Net income: CN¥1.52b (up 98% from 1Q 2021). Profit margin: 19% (down from 21% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 34%, compared to a 43% growth forecast for the industry in China. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 39% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 23
Third quarter 2021 earnings released: EPS CN¥1.24 (vs CN¥0.29 in 3Q 2020) The company reported a strong third quarter result with improved earnings, revenues and profit margins. Third quarter 2021 results: Revenue: CN¥9.25b (up 233% from 3Q 2020). Net income: CN¥2.13b (up 398% from 3Q 2020). Profit margin: 23% (up from 15% in 3Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has increased by 80% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Sep 30
Investor sentiment deteriorated over the past week After last week's 16% share price decline to CN¥36.70, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 370% over the past three years. Valuation Update With 7 Day Price Move • Aug 06
Investor sentiment improved over the past week After last week's 16% share price gain to CN¥42.17, the stock trades at a forward P/E ratio of 15x. Average forward P/E is 19x in the Chemicals industry in China. Total returns to shareholders of 543% over the past three years. Reported Earnings • Jul 27
Second quarter 2021 earnings released: EPS CN¥0.80 (vs CN¥0.28 in 2Q 2020) The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: CN¥7.15b (up 129% from 2Q 2020). Net income: CN¥1.36b (up 213% from 2Q 2020). Profit margin: 19% (up from 14% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has increased by 71% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • May 01
First quarter 2021 earnings released: EPS CN¥0.62 (vs CN¥0.04 in 1Q 2020) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2021 results: Revenue: CN¥3.62b (up 119% from 1Q 2020). Net income: CN¥766.6m (up CN¥726.3m from 1Q 2020). Profit margin: 21% (up from 2.4% in 1Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 27% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Reported Earnings • Apr 14
Full year 2020 earnings released: EPS CN¥1.52 (vs CN¥1.20 in FY 2019) The company reported a decent full year result with improved earnings and profit margins, although revenues were flat. Full year 2020 results: Revenue: CN¥10.8b (flat on FY 2019). Net income: CN¥1.66b (up 31% from FY 2019). Profit margin: 15% (up from 12% in FY 2019). Over the last 3 years on average, earnings per share has increased by 16% per year but the company’s share price has increased by 37% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Mar 25
Investor sentiment deteriorated over the past week After last week's 18% share price decline to CN¥33.65, the stock trades at a forward P/E ratio of 13x. Average forward P/E is 22x in the Chemicals industry in China. Total returns to shareholders of 117% over the past three years. Is New 90 Day High Low • Feb 09
New 90-day high: CN¥45.01 The company is up 73% from its price of CN¥25.97 on 11 November 2020. The Chinese market is up 4.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 15% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥2.92 per share. Valuation Update With 7 Day Price Move • Feb 01
Investor sentiment improved over the past week After last week's 17% share price gain to CN¥38.70, the stock is trading at a trailing P/E ratio of 32.9x, up from the previous P/E ratio of 28.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 154%. Is New 90 Day High Low • Jan 21
New 90-day high: CN¥31.50 The company is up 52% from its price of CN¥20.79 on 23 October 2020. The Chinese market is up 8.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share. Valuation Update With 7 Day Price Move • Jan 08
Investor sentiment improved over the past week After last week's 15% share price gain to CN¥30.10, the stock is trading at a trailing P/E ratio of 25.6x, up from the previous P/E ratio of 22.2x. This compares to an average P/E of 35x in the Chemicals industry in China. Total returns to shareholders over the past three years are 68%. Is New 90 Day High Low • Jan 06
New 90-day high: CN¥28.67 The company is up 40% from its price of CN¥20.44 on 09 October 2020. The Chinese market is up 11% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.53 per share. Valuation Update With 7 Day Price Move • Nov 10
Market bids up stock over the past week After last week's 18% share price gain to CN¥26.30, the stock is trading at a trailing P/E ratio of 22.3x, up from the previous P/E ratio of 18.9x. This compares to an average P/E of 39x in the Chemicals industry in China. Total returns to shareholders over the past year are 102%. Is New 90 Day High Low • Oct 30
New 90-day high: CN¥22.15 The company is up 21% from its price of CN¥18.30 on 31 July 2020. The Chinese market is down 2.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 2.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥4.03 per share. Analyst Estimate Surprise Post Earnings • Oct 28
Third-quarter earnings released: Revenue misses expectations Third-quarter revenue missed analyst estimates by 10.0% at CN¥2.78b. Revenue is forecast to grow 92% over the next year, compared to a 44% growth forecast for the Chemicals industry in China. Reported Earnings • Oct 28
Third quarter earnings released Over the last 12 months the company has reported total profits of CN¥1.25b, up 1.0% from the prior year. Total revenue was CN¥10.3b over the last 12 months, down 7.3% from the prior year. Is New 90 Day High Low • Oct 15
New 90-day high: CN¥21.48 The company is up 20% from its price of CN¥17.93 on 17 July 2020. The Chinese market is up 5.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 14% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.42 per share. Is New 90 Day High Low • Sep 21
New 90-day high: CN¥20.59 The company is up 35% from its price of CN¥15.20 on 23 June 2020. The Chinese market is up 14% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 23% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is CN¥3.44 per share.